Natasha S. Crowcroft

14.1k total citations · 4 hit papers
262 papers, 8.2k citations indexed

About

Natasha S. Crowcroft is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, Natasha S. Crowcroft has authored 262 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 202 papers in Epidemiology, 94 papers in Health and 69 papers in Infectious Diseases. Recurrent topics in Natasha S. Crowcroft's work include Vaccine Coverage and Hesitancy (93 papers), Influenza Virus Research Studies (75 papers) and Virology and Viral Diseases (52 papers). Natasha S. Crowcroft is often cited by papers focused on Vaccine Coverage and Hesitancy (93 papers), Influenza Virus Research Studies (75 papers) and Virology and Viral Diseases (52 papers). Natasha S. Crowcroft collaborates with scholars based in Canada, United Kingdom and United States. Natasha S. Crowcroft's co-authors include Shelley L. Deeks, Julia Granerød, Laura C. Rosella, Jeffrey C. Kwong, David Brown, Shelly Bolotin, Nicholas Davies, Jonathan B. Gubbay, Richard Pebody and Allison McGeer and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Natasha S. Crowcroft

256 papers receiving 7.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study

2010 876 citations David Brown, Natasha S. Crowcroft et al. profile →
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection

2018 773 citations Jeffrey C. Kwong, Kevin L. Schwartz et al. New England Journal of Medicine profile →
The basic reproduction number (R0) of measles: a systematic review

2017 385 citations Shelly Bolotin, Shelley L. Deeks et al. profile →
Progress Toward Measles Elimination — Worldwide, 2000–2022

2023 127 citations Anna A. Minta, Matt Ferrari et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Natasha S. Crowcroft Canada	43	4.8k	2.8k	1.8k	1.3k	1.1k	262	8.2k
Nicola P. Klein United States	52	5.5k 1.2×	2.8k 1.0×	2.9k 1.6×	2.1k 1.6×	628 0.6×	295	10.0k
Robert T. Chen United States	42	2.6k 0.6×	2.6k 0.9×	2.0k 1.1×	641 0.5×	513 0.5×	128	6.7k
Karen R. Broder United States	38	6.1k 1.3×	2.3k 0.8×	2.7k 1.5×	993 0.8×	293 0.3×	91	8.5k
Alberto Eugenio Tozzi Italy	45	3.2k 0.7×	1.6k 0.6×	849 0.5×	1.8k 1.4×	257 0.2×	229	7.2k
Janet A. Englund United States	72	12.4k 2.6×	6.3k 2.3×	1.6k 0.9×	2.3k 1.8×	481 0.4×	405	16.9k
Ulrich Heininger Switzerland	50	6.0k 1.3×	2.3k 0.8×	1.6k 0.9×	3.4k 2.6×	437 0.4×	311	9.1k
Shamez Ladhani United Kingdom	61	7.3k 1.5×	3.6k 1.3×	1.1k 0.6×	4.4k 3.4×	688 0.6×	382	14.4k
Eric Weintraub United States	47	6.9k 1.4×	3.8k 1.3×	3.0k 1.6×	723 0.6×	550 0.5×	176	11.5k
Richard Pebody United Kingdom	54	6.9k 1.4×	3.0k 1.1×	1.1k 0.6×	1.1k 0.8×	165 0.2×	297	10.0k
Peter McIntyre Australia	52	7.5k 1.6×	2.4k 0.9×	2.5k 1.4×	4.1k 3.2×	267 0.2×	389	10.7k

Countries citing papers authored by Natasha S. Crowcroft

Since Specialization

Citations

This map shows the geographic impact of Natasha S. Crowcroft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natasha S. Crowcroft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natasha S. Crowcroft more than expected).

Fields of papers citing papers by Natasha S. Crowcroft

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natasha S. Crowcroft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natasha S. Crowcroft. The network helps show where Natasha S. Crowcroft may publish in the future.

Co-authorship network of co-authors of Natasha S. Crowcroft

This figure shows the co-authorship network connecting the top 25 collaborators of Natasha S. Crowcroft. A scholar is included among the top collaborators of Natasha S. Crowcroft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natasha S. Crowcroft. Natasha S. Crowcroft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bolotin, Shelly, Jim Wright, Elizabeth McLachlan, et al.. (2025). Investigating the measles susceptibility gap in Ontario infants. Vaccine. 54. 126908–126908. 1 indexed citations

Minta, Anna A., Matt Ferrari, Sébastien Antoni, et al.. (2024). Progress Toward Measles Elimination — Worldwide, 2000–2023. MMWR Morbidity and Mortality Weekly Report. 73(45). 1036–1042. 30 indexed citations

Hsu, Christopher H., Yvan Hutin, Nadia Teleb, et al.. (2024). Progress Toward Measles Elimination — World Health Organization Eastern Mediterranean Region, 2019–2022. MMWR Morbidity and Mortality Weekly Report. 73(7). 139–144. 12 indexed citations

O’Connor, Patrick, Balcha Masresha, José E. Hagan, et al.. (2024). Global Status Report for the Verification of Measles and Rubella Elimination, 2022. Vaccines. 12(8). 947–947. 4 indexed citations

Chung, Hannah, Michael A. Campitelli, Sarah A. Buchan, et al.. (2023). Evaluating the Impact of Statin Use on Influenza Vaccine Effectiveness and Influenza Infection in Older Adults. Clinical Infectious Diseases. 77(2). 303–311. 4 indexed citations

Savage, Rachel, Laura C. Rosella, Natasha S. Crowcroft, et al.. (2019). Direct Medical Costs of 3 Reportable Travel-Related Infections in Ontario, Canada, 2012–2014. Emerging infectious diseases. 25(8). 1501–1510. 3 indexed citations

Wilson, Sarah E., Laura C. Rosella, Jun Wang, et al.. (2019). Equity and impact: Ontario’s infant rotavirus immunization program five years following implementation. A population-based cohort study. Vaccine. 37(17). 2408–2414. 7 indexed citations

Kwong, Jeffrey C., Kevin L. Schwartz, Michael A. Campitelli, et al.. (2018). Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. New England Journal of Medicine. 378(4). 345–353. 773 indexed citations breakdown →

Wilson, Lindsay A., Malia S. Q. Murphy, Cindy Jardine, et al.. (2018). Barriers to immunization among newcomers: A systematic review. Vaccine. 36(8). 1055–1062. 86 indexed citations

10.

Wilson, Sarah E., Susan Quach, Shannon E. MacDonald, et al.. (2016). Immunization information systems in Canada: Attributes, functionality, strengths and challenges. A Canadian Immunization Research Network study. Canadian Journal of Public Health. 107(6). e575–e582. 20 indexed citations

11.

Rosella, Laura C., et al.. (2014). Ethnic disparities in acquiring 2009 pandemic H1N1 influenza: a case–control study. BMC Public Health. 14(1). 214–214. 22 indexed citations

12.

Wagner, Karen, Joanne White, Shona Neal, et al.. (2013). Screening for Corynebacterium diphtheriae and Corynebacterium ulcerans in patients with upper respiratory tract infections 2007-2008: a multicentre European study. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 6 indexed citations

13.

Chu, Anna, Rachel Savage, Michael Whelan, et al.. (2013). Assessing the Relative Timeliness of Ontario’s Syndromic Surveillance Systems for Early Detection of the 2009 Influenza H1N1 Pandemic Waves. Canadian Journal of Public Health. 104(4). e340–e347. 9 indexed citations

14.

Kwong, Jeffrey C., Michael A. Campitelli, Jonathan B. Gubbay, et al.. (2013). Vaccine Effectiveness Against Laboratory-Confirmed Influenza Hospitalizations Among Elderly Adults During the 2010-2011 Season. Clinical Infectious Diseases. 57(6). 820–827. 48 indexed citations

15.

Janjua, Naveed Z., Danuta M. Skowronski, Gaston De Serres, et al.. (2012). Estimates of Influenza Vaccine Effectiveness for 2007–2008 From Canada's Sentinel Surveillance System: Cross-Protection Against Major and Minor Variants. The Journal of Infectious Diseases. 205(12). 1858–1868. 48 indexed citations

16.

Wilson, Sarah E., et al.. (2012). Ontario’s School-based HPV Immunization Program: School Board Assent and Parental Consent. Canadian Journal of Public Health. 103(1). 34–39. 17 indexed citations

17.

Wilson, Kumanan, Steven Hawken, Jeffrey C. Kwong, et al.. (2012). On-time Vaccination Coverage in Premature Infants in Ontario, 2002–2009. Canadian Journal of Public Health. 103(5). e359–e362. 12 indexed citations

18.

Scheifele, David W., et al.. (2011). Optimizing Canadian Public Immunization Programs: A Prescription for Action. Canadian Journal of Public Health. 102(3). 193–195. 1 indexed citations

19.

Heidebrecht, Christine, Jennifer Pereira, Susan Quach, et al.. (2011). Approaches to Immunization Data Collection Employed Across Canada During the Pandemic (H1N1) 2009 Influenza Vaccination Campaign. Canadian Journal of Public Health. 102(5). 349–354. 3 indexed citations

20.

Crowcroft, Natasha S., et al.. (2002). Las fiebres hemorrágicas víricas en Europa: su control eficaz exige una respuesta coordinada. Eurosurveillance. 7(3). 31–32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact